Loss-of-function mutations in the genes encoding dystrophin and the associated membrane proteins, the sarcoglycans, produce muscular dystrophy and cardiomyopathy. The dystrophin complex provides stability to the plasma membrane of striated muscle during muscle contraction. Increased SMAD signaling due to activation of the transforming growth factor-b (TGFb) pathway has been described in muscular dystrophy; however, it is not known whether this canonical TGFb signaling is pathogenic in the muscle itself. Drosophila deleted for the g/d-sarcoglycan gene (Sgcd) develop progressive muscle and heart dysfunction and serve as a model for the human disorder. We used dad-lacZ flies to demonstrate the signature of TGFb activation in response to exercise-induced injury in Sgcd null flies, finding that those muscle nuclei immediately adjacent to muscle injury demonstrate high-level TGFb signaling. To determine the pathogenic nature of this signaling, we found that partial reduction of the co-SMAD Medea, homologous to SMAD4, or the r-SMAD, Smox, corrected both heart and muscle dysfunction in Sgcd mutants. Reduction in the r-SMAD, MAD, restored muscle function but interestingly not heart function in Sgcd mutants, consistent with a role for activin but not bone morphogenic protein signaling in cardiac dysfunction. Mammalian sarcoglycan null muscle was also found to exhibit exercise-induced SMAD signaling. These data demonstrate that hyperactivation of SMAD signaling occurs in response to repetitive injury in muscle and heart. Reduction of this pathway is sufficient to restore cardiac and muscle function and is therefore a target for therapeutic reduction.
INTRODUCTION
Mutations in the genes encoding dystrophin and its associated proteins lead to muscular dystrophy and cardiomyopathy in vertebrates and invertebrates. Dystrophin associates with a composite of transmembrane proteins including dystroglycan, sarcospan, syntrophins and the sarcoglycan proteins to mediate stability of the plasma membrane of muscle (1) . Dystrophin links to cystoskeletal actin, and dystroglycan binds laminin in the extracellular matrix connecting the cytoskeleton and the matrix (2) . This organization supports a role for the dystrophin complex in preserving the mechanical integrity of the plasma membrane. In addition to this mechanical support, additional roles have been proposed, including regulation of nitric oxide, calcium homeostasis and MAP kinase signaling (1, 3) .
The dystrophin complex contributes to a mechanically strong link between the cytoskeleton and the plasma membrane. In the face of muscle contraction, muscle lacking dystrophin displays more injury than normal muscle (4, 5) . This is particularly evident when muscle is subject to eccentric contraction, a protocol where lengthened muscle is repetitively subjected to contraction to produce strain on the sarcolemma. In the mdx mouse that lacks dystrophin, the diaphragm muscle displays the greatest degree of disease pathology, nearly on par with what is seen in human muscle (4, 6) . Loss-of-function * To whom correspondence should be addressed at: 5841 S. Maryland, MC 6088, Chicago, IL 60637, USA. Tel: +1 7737022672; Fax: +1 7737022681; Email: emcnally@uchicago.edu mutations in the genes encoding the sarcoglycan subunits also lead to muscular dystrophy and cardiomyopathy similar to what is seen from dystrophin mutations. Interestingly, loss of g-sarcoglycan does not render muscle more susceptible to eccentric contraction-induced damage, highlighting the nonmechanical aspects of the dystrophin complex (7) . The vital tracer, Evans Blue Dye, a small molecule that binds albumin, has been used to document membrane disruption in vivo in the muscular dystrophies. Dye uptake can be readily detected in muscle lacking dystrophin or the sarcoglycan subunits (8 -10) , indicating that a loss of any of these proteins is sufficient to destabilize the plasma membrane. The fragile muscle membrane coupled with repetitive insult from exercise and contraction leads to progressive myofiber loss.
Dystrophic muscle is characterized by progressive replacement of the muscle fibers by fibrosis. Transforming growth factor-b (TGFb) is known to contribute to the fibrotic response in a number of pathological processes such as pulmonary fibrosis, liver cirrhosis and renal disease. Increased TGFb signaling has also been noted in human and murine muscular dystrophy. In dystrophic muscle biopsies taken from patients with Duchenne muscular dystrophy, TGFb1 is localized near and within injured muscle fibers (11) . Moreover, reducing TGFb signaling in the mdx mouse model, either using TGFb-neutralizing antibodies or angiotensin receptor blockers, improved muscle regeneration and reduced fibrosis in mdx mice (12) . However, others have shown that TGFb-neutralizing antibodies reduced fibrosis but also produced an unfavorable cytokine profile in mdx diaphragm muscle (13) . The role of TGFb in muscular dystrophy was also reinforced by the recent observation that Ltbp4, a gene encoding a TGFb-sequestering protein, serves as a genetic modifier of muscular dystrophy where reduced TGFb signaling was associated with reduced membrane disruption and reduced fibrosis (14) . Cumulatively, these data demonstrate that TGFb signaling, at the level of matrix release and receptor activation, is critical for muscular dystrophy pathogenesis. However, whether and which downstream TGFb-signaling pathways mediate disease has not been explored.
The utility of Drosophila models of human disease is promoted by the comparatively more rapid genetic analyses that can be conducted. We previously generated a muscular dystrophy model in Drosophila melanogaster using imprecise P element excision to generate deletions in the gene encoding g/d-sarcoglycan [Sgcd, Flybase Scgd (15)]. In Drosophila, there is only a single sequence equally related to mammalian Sgcg and Sgcd, referred to as Sgcd. Sgcd-deleted flies develop normally but with age, muscle tears become apparent, climbing ability declines and the heart tube enlarges and develops reduced contractility. This mirrors what is seen in humans with muscular dystrophy and mouse models of the disease. Drosophila models of muscular dystrophy also include mutations that affect of dystrophin (Dys) or dystroglycan (Dg), altered via RNA interference, overlapping deletions, hypomorphic mutations or mutations in putative dystroglycan glycosylating enzymes (16) (17) (18) (19) . These perturbations also result in heart and muscle deficits, providing genetic evidence for evolutionary conservation of dystrophin and its associated proteins. Extramuscle features are present in some of these mutants, underscoring the role of the dystrophin complex in other cell types and potentially providing surrogate phenotypes for study (18, 20, 21) . However, a striking difference is that Drosophila Sgcd null muscle does not develop increased fibrosis, and therefore offers the opportunity to examine the role of TGFb as a direct mediator of muscle disease and dysfunction.
In the canonical TGFb-signaling pathway, TGFb family ligands bind to type II TGFb receptors (22) . These receptors bind and phosphorylate type I receptors. This triggers phosphorylation of a signal transduction molecule, the r-SMAD, at its carboxy-terminal SSXS motif. Phosphorylated r-SMADs bind to co-SMADs, translocate to the nucleus and direct changes in gene transcription (23) . In Drosophila, there are two r-SMADs. Mothers against dpp (MAD) is homologous to mammalian SMADs 1, 5 and 8 and is phosphorylated in response to bone morphogenic protein (BMP) family signaling. Smad on X (Smox) is homologous to SMADs 2 and 3, and is phosphorylated in response to activin signaling. There is a single co-SMAD, Medea, which is functionally homologous to SMAD4. This lack of redundancy means that mutations of either r-SMAD will affect the entire corresponding family of TGFb ligands and mutations of Medea will decrease all TGFb receptor-induced signaling. Significantly, there is not a precise ortholog of TGFb in Drosophila.
We now used the Sgcd null fly to investigate whether increased TGFb signaling drives progression of muscular dystrophy. We found that exercise causes increased muscle injury in the Sgcd[840] mutant fly. Using a reporter of TGFb activity, we find that TGFb signaling occurs in myonuclei immediately adjacent to the sites of muscle injury in the Sgcd[840] mutant. We show that genetically decreasing SMAD signaling using haploinsufficient alleles was sufficient to rescue skeletal and cardiac muscle dysfunction in this mutant. Finally, we show that exercise increases SMAD activity in the Sgcg null mouse and notably does so in centrally placed nuclei immediately after exercise. These findings identify a central role for SMAD signaling in the progression of muscular dystrophy.
RESULTS

Exercise induces muscle disruption in Sgcd[840] mutants
Deletion mutants in Sgcd were generated using imprecise P element-mediated excision (15) . We selected the Sgcd[840] line for analysis since this line has a molecular defined genetic deletion encompassing exons 1 -4. Exon 2 encodes the initiator methionine and the complete cytoplasmic and transmembrane domains, and the deletion in the Sgcd [840] line is associated with no detectable sarcoglycan protein expression. In some mammalian models of muscular dystrophy, notably those lacking dystrophin and d-sarcoglycan, muscle contraction enhances muscle damage (4, 6, 8) . The standard vial used to house Drosophila greatly limits the opportunity to utilize the indirect flight muscles. To determine whether exercise induces damage in the Drosophila Sgcd[840] line, we evaluated mutant and wild-type flies that housed in a 20 × 20 × 20 cm box to permit ad libitum flight from eclosion to 14 days of age. The volume in these boxes was approximately 300 times greater than a vial, providing Fig. S1 ). Mutant Drosophila muscle only rarely showed the amorphous material in Figure 1 and never displayed the interstitial fibrosis derived from fibroblasts that characterize mammalian dystrophic muscle. Because Drosophila muscle lacks fibrosis, this model is highly useful to study the myogenic component of muscle dysfunction.
Exercise-induced muscle tears in the Sgcd[840] mutant lead to SMAD signaling Because enhanced TGFb signaling has been implicated as pathogenic in human and murine muscular dystrophy, we investigated whether increased SMAD signaling was present in the Sgcg[840] line. We introduced the dad-lacZ reporter into the Sgcd[840] background. dad-lacZ is an insertion of a lacZ enhancer trap element near the daughters against decapentaplegic (dad) gene and is homologous to mammalian SMAD7 (25) . In flies bearing the dad-lacZ allele, b-galactosidase (b-gal) is synthesized in response to TGFb signaling. We generated Sgcd[840] mutant flies that also carried the dad-lacZ reporter, as well as the balancer chromosome TM3 which prevents recombination and loss of the dad-lacZ insertion. Sgcd[+]; dad-lacZ/TM3 and Sgcd[840]; dad-lacZ/TM3 males were aged in either ordinary vials or flight boxes for 14 days to represent sedentary and exercised, respectively. Flies were collected and evaluated for b-gal activity. Extensive b-gal activity was evident in muscle nuclei in exercised Sgcd[840]; dad-lacZ/TM3 flies. Those myonuclei immediately adjacent to muscle disruption showed the greatest increase in b-gal activity (Fig. 2 ) consistent with a model where injury itself triggers TGFb signaling. To assess this, we injured wild-type muscle using needle penetration and found a similar pattern of dad-mediated b-gal activity (Supplementary Material, Fig. S2 ). Therefore, muscle injury itself is characterized by enhanced TGFb signaling. In Sgcd[840] flies, exercise is sufficient to induce muscle injury and then elicit increased dad activity.
TGFb signaling is increased in Sgcd[840] mutant muscle
We quantified TGFb signaling in Sgcd[840] with the dad-lacZ reporter by measuring b-gal activity (26) . Since we were primarily interested in signaling within muscle, thoraces were isolated. This portion of the fly body is largely composed of the indirect flight muscles. When comparing sedentary flies, (Fig. 3 ). These data are consistent with a model where increased activity in the presence of the Sgcd mutation produces muscle tearing, which, in turn, triggers increased SMAD signaling. In sedentary flies, where there is less activity and less muscle disruption, SMAD signaling is not activated above background. Wild-type and mutant flies within each group were compared in the same setting. However, due to variability in conditions and the fact that exercised and unexercised flies were assayed at different times, the results cannot be directly compared between sedentary and exercised flies.
To validate the quantitative nature of this assay, we tested the responsiveness of dad-lacZ to mutations in the TGFb signaling gene Medea. Each of three mutations was independent. We tested Medea [13] , Medea [15] or Medea [17] as (Fig. 4A , n ¼ 19, P , 0.001). We repeated this experiment with Medea [15] and Medea [17] and found that each allele as a heterozygote resulted in similar complete correction of the walking defect. 
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We asked whether these functional improvements correlated to improvement in the morphological abnormalities we previously identified. (Fig. 5B , n ¼ 20, P , 0.001). Of note, with this assay, there was variation between wild-type (Or-R flies) assayed on different days (compare Fig. 5A and B) . We attribute this difference to environmental variability such as temperature and humidity, and for this reason only compared mutants and WT evaluated simultaneously.
Reducing TGFb signaling rescues heart function in sarcoglycan mutant flies
Humans and mice with muscular dystrophy develop cardiomyopathy. Similarly, Sgcd mutant flies have a dilated and poorly contractile heart tube (15). This can be measured using optical coherence tomography (OCT) as increased endsystolic and end-diastolic diameter and reduced measurements of performance (29) . To determine whether reducing SMAD signaling would improve heart function, we assayed the heart tube function of Sgcd[840] flies containing the Medea [13] , MAD [12] (29) since this method allows quantitative measures of heart function. We measured end-systolic diameter, end-diastolic diameter and heart rate. Heart rate did not vary between any groups (data not shown). Introducing Medea [13] or Smox[G0348] mutations as heterozygotes restored endsystolic and end-diastolic diameters, and thus returned heart function to wild-type levels (Fig. 6) . MAD [12] failed to improve heart function, suggesting BMP signaling contributes more to muscle than heart tube dysfunction since BMP disruption was sufficient to correct muscle dysfunction.
Exercise induces TGFb signaling in Sgcg null mice
To translate our findings into a mammalian model of muscular dystrophy, we studied mice lacking g-sarcoglycan (Sgcg null) (9) . Drosophila Sgcd is 30-35% identical to both mouse g-and d-sarcoglycan, showing equal relationship with the two murine genes. Loss-of-function mutations in human Sgcg or Sgcd cause muscular dystrophy and cardiomyopathy similar to what develops from dystrophin mutations (30, 31) . Mice null for Sgcg or Sgcd also display a similar phenotype of heart and muscle disease (8, 9, 32) . To determine whether exercise contributes to TGFb signaling in this model of muscular dystrophy, we exercised Sgcg null and WT mice at 10 m/min for 30 min with a 78 downward angle. Compared with unexercised controls, exercised Sgcg null mice displayed increased nuclear phosphorylated SMAD2/3 (pSMAD, Fig. 7) . We quantified the increase by counting the number of central myonuclei that stained for pSMAD2/3. By confining our analysis to central nuclei, we ensured that the nuclei we counted were muscle nuclei, rather than fibroblasts or infiltrating immune cells. In sedentary Sgcg null mice, 21 + 13% of nuclei were positive, as compared with 82 + 7% in exercised Sgcg null mutants, (P , 0.01). Of note, there were many extramyofiber nuclei, those found in fibroblasts and infiltrating inflammatory cells were strongly pSMAD2/3 positive. WT mice did not show central nuclei, and had minimal pSMAD2/3, regardless of exercise. The finding that exercise increased the pSMAD signaling in myonuclei indicates a direct effect on myofibers. Therefore, in mammalian muscle, as in Drosophila muscle, the combination of exercise and disruption of the dystrophin -sarcoglycan complex results in increased TGFb signaling.
DISCUSSION
Enhanced TGFb signaling characterizes muscle injury and disease
TGFb signaling is mediated through canonical and noncanonical pathways. In mammalian muscle, pSMAD is detected in nuclei, and reduction of nuclear pSMAD was reported in mdx mice treated with TGFb-neutralizing antibodies (12) . In dystrophic muscle, both myonuclei and those Exercise induces SMAD signaling in Sgcg null mice. Sgcg 2/2 mice were either exercised by running downhill at 10 m/min for 30 min at a 78 down angle (exercised) or not (sedentary). Nuclear pSMAD2/3 was evident in sedentary Sgcg 2/2 mice, particularly in the centrally located nuclei of regenerating fibers (arrowheads); however, pSMAD2/3 staining in myonuclei was much more pronounced in the Sgcg 2/2 muscle that had been subjected to exercise. Nuclear pSMAD2/3 was not exclusive to centrally placed myonuclei since many non-central nuclei showed this staining. To ensure that myonuclei were being quantified, as opposed to infiltrating inflammatory cells or fibroblasts, we compared nuclear pSMAD only in centrally positioned myonuclei. Exercise dramatically increased nuclear pSMAD2/3. Since this analysis was conducted immediately post-exercise, with insufficient time for regeneration, this supports the model where exercise promotes injury and triggers pathogenic pSMAD signaling in muscle nuclei. pSMAD2/3 was not seen in wild-type mice under any of these conditions. * * P , 0.01 versus sedentary. Red, pSMAD2/3. Green, Alexa 488 Phalloidin to highlight myofibers. Blue, DAPI to show nuclei. Scale bar, 10 mm.
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Human Molecular Genetics, 2011, Vol. 20, No. 5 nuclei in non-muscle cells display enhanced nuclear pSMAD (12) . We now show that the orthologous SMAD-type signaling is increased in a Drosophila model of muscular dystrophy. We utilized the fly model for these studies because dystrophic fly muscle is characterized by a degenerative process. This is in contrast to dystrophic mammalian muscle where there is degeneration alongside regeneration and infiltration by non-muscle elements. Because in mammalian muscle these non-muscle elements, particularly the fibroblasts, have much greater pSMAD signaling, the simpler fly muscle allowed us to examine the myogenic component of injury response.
With this approach, we found that exercise enhanced muscle disruption and the degree of b-gal activity from the dad-lacZ indicator allele in Sgcd[840] muscle. The myonuclei most proximal to the region of disruption displayed the greatest amount of b-gal activity, and this is consistent with a model of local TGFb activity inducing response nearest to the area of injury. Injury alone, in the absence of disease, also elicited this signaling response, if the injury was severe. Apidianakis et al. (33) profiled gene expression of mechanically injured Drosophila thorax and found elevated transcript levels for the BMP-like ligand gbb and the activin ligand daw at 1 and 6 h after injury, suggesting that these ligands may be the TGFb orthologs. In addition to fibroblast activation and proliferation, mammalian muscular dystrophy is accompanied by an inflammatory response in muscle, in part mediated by mononuclear cells derived from the bone marrow. The equivalent in the fly is a hemocyte-like cell, which we very occasionally observed in sarcoglycan mutant flies. Hemocyte-derived cell lines are known to secrete TGFb family ligands (34) . However, this behavior has not been investigated in Drosophila adult muscle. In mammalian models of muscular dystrophy, immune cells are prominent and a plausible source of TGFb and other cytokines (35) . The use of the dad-lacZ indicator demonstrated that muscle cells clearly possess the capacity to respond to downstream signaling. In mammalian muscle, the finding of myofiber nuclei positive for pSMAD2/3 supports a parallel pathogenesis in mammalian muscle.
TGFb in regeneration and degeneration in muscular dystrophy
In mammalian muscle affected by muscular dystrophy, degeneration occurs concomitantly with regeneration. In this model reducing TGFb signaling was thought to primarily mediate its effect by improving muscle regeneration, suggesting that TGFb signaling has a negative effect on satellite cell function (12) . Although the Sgcd[840] model exhibits many features of mammalian muscular dystrophy, we previously did not find evidence of muscle regeneration in this model (15) . The absence of obvious regeneration in the fly model suggests that enhanced TGFb signaling is exerting its effect directly by hastening muscle degeneration either by inhibiting membrane-mediated repair mechanisms or other cellular adaptations. Our findings suggest that the effects of inhibiting TGFb signaling likely extend beyond the regenerative response, mitigating degeneration and enhancing repair. An additional possibility, raised by the improved climbing performance of normal flies with heterozygous SMAD alleles, is that reducing SMAD signaling developmentally increases muscle function, perhaps by antagonizing the myostatin homolog, myoglianin (36) . Further understanding the genes regulated by nuclear pSMADs in injured muscle may help to define the precise pathways that are most critical for eliciting muscle dysfunction. Our results thus far point to the r-SMADs and co-SMADs as targets for therapeutic intervention.
We found that exercising a mouse model of muscular dystrophy increased the pSMAD signaling in those nuclei positioned centrally within myofibers. Centrally positioned nuclei, as opposed to those in the normal peripheral position, are indicative of recent regeneration. However, in our studies, we detected increased pSMAD in central nuclei immediately after exercise without sufficient time for myoblast fusion and regeneration. We interpret these findings to indicate that all myonuclei, including those in the central position, are affected by pathogenic TGFb signaling. Newly regenerated fibers are particularly important to protect and so targeting this pathway for therapy may offer additional protection.
Sgcd[840]
heart and muscle exhibit divergent responses to MAD [12] We found that heterozygous mutations of Medea, Smox or MAD were dominant suppressors of the loss of walking function in Sgcd[840] mutants. This finding implicates broad downstream signaling, including both the activin and BMP pathways. Curiously, the MAD [12] allele did not improve heart tube function while the Medea [13] and Smox[G0348] alleles did. MAD [12] is the r-SMAD for BMP, and therefore the differential response of the heart tube versus skeletal muscle implies that BMP is more important for muscle versus heart tube function. The Drosophila heart tube is a linear structure. During larval stages, the posterior region is lined with cells expressing cardiac-specific markers (37) . Expression of the Hox gene AbdA is sufficient to determine the cardiac fate while the anterior portion is the aorta (37) . In the adult, the more anterior segments, A1 through A4, assume cardiac function and are lined with cardiomyocytes derived from the larval cells (38) . This developmental paradigm suggests a more intimate relationship between cardiac and vascular structures where activin but not BMP signaling may be essential. Although the SMAD family is more complex in mammals, there still may a differential response to SMAD reduction between heart and skeletal muscles, as inhibition of SMAD signaling may differ between vascular cells and skeletal muscle in mammals.
This study focused on canonical TGFb signaling in the Sgcd[840] model. Non-canonical TGFb signaling includes JNK, p38, ERK and Akt signaling (39) . Notably, each of these pathways has been shown to be important for muscle regeneration and function. P38 MAP kinase and JNK2 signaling are induced by an exercise regimen in the mdx mouse (40) . Akt mediates the muscle proliferative and differentiation functions of insulin-like growth factor-1 (41) . In addition, SMADs are not exclusively activated by TGFb receptors, and the non-transcription factor roles of SMADs should be Human Molecular Genetics, 2011, Vol. 20, No. 5 901 considered (42) when targeting these pathways for therapeutic intervention.
MATERIALS AND METHODS
Fly stocks
Oregon-R-S (Or-R) was used as the wild-type in all experiments except heart function, which used w Quantitative b-gal assay b-gal was quantified essentially as described (26) . Individual flies were briefly anesthetized with CO 2 , thoraces were dissected and then homogenized in 100 ml assay buffer (50 mM KHPO 4 , 1 mM MgCl 2 , pH 7.5) in a 1.5 ml centrifuge tube using a Kontes Pellet Pestle homogenizer and appropriate pestles (Fisher). Whole flies were homogenized in 200 ml assay buffer. Homogenates were centrifuged for 5 min at 14 000g RCF. From each fly, 50 ml of supernatant was transferred to a well on a 96-well plate (Costar), one fly or thorax per well. Then, 150 ml of assay buffer plus 1 mM chlorophenol red, b-D-galactopyranoside (CPRG, Roche) was added to each assay well. Plates were incubated at 378C and the absorbance at 584 nm was read every 2 h for 24 h using a BMG Labtech FLUOstar OPTIMA plate reader. The mean absorbance for Or-R flies was subtracted from each time point and linear regression was performed using Prism 4.0c (GraphPad). The b-gal activity presented is the slope of the regression line +SD, measured in absorbance units (AUs) at 584 nm per hour. The AUs were multiplied by 1000 and reported as units/hour. Six to eight flies or thoraxes were used per genotype per run. Data presented are representative of at least three runs on different days. Single runs are presented due to day-to-day variability in the assay.
Histology
For hematoxylin and eosin (H&E) staining, flies were fixed and wax embedded according to Fischbach (44) , then sectioned and stained using standard protocols. For histochemistry, flies were arranged in freezing medium (TFM, Triangle Biomedical Sciences) and plunged into liquid nitrogen-chilled isopentane, then liquid nitrogen alone. Mouse tissues were collected and quickly frozen. For b-gal activity staining, a published protocol was used with the modification that 2% X-gal was used instead of 10% (45) . For immunofluorescence microscopy, 10 mm sections were cut, slides were fixed for 5 min in methanol at 2208 and blocked for 1 h using block solution (5% fetal bovine serum in PBS). Primary antibody was incubated for 1 h in block solution. The anti-pSMAD2/3 (Cell Signaling no. 3101) was used at 1:50. After washing in PBS, slides were incubated with goat anti-rabbit IgG conjugated to the Cy3 fluorophore (Jackson ImmunoResearch) and phalloidin conjugated to Alexa Fluor 488. Slides were mounted in Vectashield with DAPI (Vector Labs) and imaged by an observer who was blinded to treatment and exercise status of the mice. For pSMAD2/3+ nucleus counting, five random high-power fields were captured for each condition. pSMAD2/3+ and central nuclei were scored blinded. Images were captured with an Axiophot microscope and iVision software and manipulated within NIH guidelines using Adobe Photoshop 7.0 and ImageJ.
Negative geotaxis
Negative geotaxis was tested at 14 days after eclosion. Individual flies were briefly anesthetized and loaded into 10 ml plastic pipettes affixed to a rigid vertical surface. Flies were given 30 min to recover, and then tapped to the lowest point to engage the negative geotaxis reflex. Flies were allowed to climb for 10 s. Trials were recorded, and the total movement against gravity for each fly was recorded. Groups of flies that were to be compared were assayed simultaneously to eliminate variability attributed to room temperature and room humidity. Each fly was run a total of six times with 1 min between runs. All data presented were from multiple runs on separate days, and flies were compared with flies that were run at the same time. The distance climbed for each fly and each trial was entered into Prism 4.0c. Groups were compared using one-way analysis of variance with a post hoc Tukey test and a significance level of 0.05.
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Optical coherence tomography OCT was performed as described previously (29) . Each line was assessed at 7 days after eclosion. Males were studied for all groups except those including Smox[G0348], which is lethal in males. The measured end-systolic and end-diastolic heart tube diameters for each fly were entered into Prism 4.0c.
Groups were compared using one-way analysis of variance with a post hoc Tukey test and a significance level of 0.05.
Animal care and use
Sgcg null mice were previously engineered by deleting exon 2, which encodes the initiator methionine and intracellular domain (9) . Sgcd null mice were also generated by deleting exon 2 and similarly are a null allele (8) . Sgcg null mice were bred through 10 generations into the DBA/2J background as described (46) . Exercised mice were subjected to 30 min of running at a rate of 10 m per minute and a 78 downward angle. Post-exercise, animals were sacrificed immediately and muscles were isolated. All experiments were carried out under the approval of the University of Chicago Animal Care and Use Committee.
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